Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Top articles in non–small cell lung cancer (NSCLC) include FDA approvals, improved outcomes due to certain treatments, and ...

This is a pivotal era for pharmacy, which is defined by rapid technological evolution and significant federal policy shifts.

The US saw several new and expanded FDA indications this year. The top 5 most-read FDA approvals on AJMC.com included 4 novel ...

Here are the top 5 most-read SAP articles in 2025. 5. With Remote Patient Monitoring, Picking Tools Is Easier Than Change ...

New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...

Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

The top 5 most-read obesity articles on AJMC.com in 2025 include conversations on the costs and coverage of glucagon-like ...

Our top HIV content focused primarily on domestic policies, as cuts to the President’s Emergency Plan for AIDS Relief (PEPFAR ...

Highlights from the 2025 Muscular Dystrophy Association (MDA) Conference include clinical updates, expert insights, and ...

Our top 5 highlights from the 2025 San Antonio Breast Cancer Symposium (SABCS) include articles and interviews introducing ...